Abstract
Locoregional recurrence remains one of the leading causes of disease progression following radical treatment for malignant neoplasms. Identification of risk factors associated with recurrence is essential for predicting patient outcomes, optimizing therapeutic strategies, and developing individualized follow-up programs.
References
This work is licensed under a Creative Commons Attribution 4.0 International License.